NuScale Power Corporation (NYSE:SMR) experienced a sharp pullback on Wednesday, with shares closing down 5.5% at $9.27. The decline reversed most of the gains from the previous session's AI-related rally, highlighting a persistent valuation gap between technological advancements and actual revenue generation.
The stock traded within a range of $9.06 to $10.26 during the session, with volume reaching 51.88 million shares—approximately 1.35 times the recent average. In after-hours trading, shares edged up 1.02% to $9.36, according to market data as of 19:59 EDT.
AI Pilot Shows Promise, But Commercial Impact Remains Unclear
NuScale is rolling out Nuclearn's AtomAssist platform, implemented in partnership with NPX. The AI system is designed to streamline access to engineering documents, licensing data, and technical standards. According to a company proof of concept, retrieval times were reduced by up to 80%.
Chief Technology Officer José Reyes emphasized that the tools are intended to boost team efficiency while maintaining rigorous safety and quality standards. However, NuScale did not disclose contract values, licensing fees, or anticipated cost savings from the deployment.
Financials Reveal Wide Disparity Between Innovation and Revenue
The omission is notable given the company's financial picture. Research and development expenses surged 56% in the second quarter to $18.4 million, while revenue plummeted 99% to $75,000 as previous Romanian engineering projects concluded. The operating loss widened 49% to $64.0 million, according to quarterly financial statements.
The market's reaction reflects this disconnect. On Tuesday, shares jumped 76 cents, adding roughly $327 million in market value. Wednesday's 54-cent drop erased about $232 million, based on 429.72 million shares outstanding.
Broader Sector Moves
Other early-stage reactor companies also faced headwinds. Oklo (NYSE:OKLO) declined 6.03%, and NANO Nuclear Energy (NASDAQ:NNE) slipped 3.85%. In contrast, BWX Technologies (NYSE:BWXT), a profitable nuclear supplier, advanced 2.29% following its latest reactor contract with the U.S. Army.
Analyst Views and Liquidity Position
Wall Street remains divided on NuScale's prospects. FactSet data shows six Buy ratings, nine Holds, and two Sells, with a consensus price target of $12.59 and forecasts ranging from $6 to $20.
The company's liquidity provides some cushion. As of June 30, cash and investments totaled approximately $1.9 billion, with operating cash outflow for the first half at $372.9 million, including a significant working capital draw. Stock issuance during that period generated $984.5 million.
Key Catalysts Ahead
NuScale and ENTRA1 are in discussions with the Tennessee Valley Authority regarding a potential definitive power-purchase agreement, and progress continues on a six-module project in Romania. However, as noted in the second-quarter update, neither effort is currently generating binding revenue from reactor delivery.
Investors should note that the AI efficiency gains stem from a preliminary proof of concept and may not accelerate licensing or construction timelines. Significant risks include customer financing, regulatory approval, supply chain limitations, and potential further dilution.
For now, an 80% improvement in search speed is helpful but insufficient on its own. A lasting revaluation will require verifiable cost reductions, secured contracts, or reported revenue. Wednesday's decline underscores this fundamental reality.
